Stockreport

This Biotech Stock Is Up 158% in a Year. What's Driving It Higher? [Yahoo! Finance]

Insight Molecular Diagnostics Inc.  (IMDX) 
PDF IMDX has surged 158% over the past year and is trading at a new two-year high. Shares maintain a 100% “Buy” opinion from Barchart. Analyst sentiment is mixed, with [Read more]